NO20013369D0 - Arylpiperazinyl-cykloheksyl-indol-derivater for behandling av depresjon - Google Patents
Arylpiperazinyl-cykloheksyl-indol-derivater for behandling av depresjonInfo
- Publication number
- NO20013369D0 NO20013369D0 NO20013369A NO20013369A NO20013369D0 NO 20013369 D0 NO20013369 D0 NO 20013369D0 NO 20013369 A NO20013369 A NO 20013369A NO 20013369 A NO20013369 A NO 20013369A NO 20013369 D0 NO20013369 D0 NO 20013369D0
- Authority
- NO
- Norway
- Prior art keywords
- arylpiperazinyl
- cyclohexyl
- depression
- treatment
- indole derivatives
- Prior art date
Links
- 208000020401 Depressive disease Diseases 0.000 title 1
- 229940054051 antipsychotic indole derivative Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/08—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing alicyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/02—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
- C07D295/027—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring
- C07D295/033—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring with the ring nitrogen atoms directly attached to carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US22658399A | 1999-01-07 | 1999-01-07 | |
| PCT/US2000/000223 WO2000040554A1 (en) | 1999-01-07 | 2000-01-06 | Arylpiperazinyl-cyclohexyl indole derivatives for the treatment of depression |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20013369D0 true NO20013369D0 (no) | 2001-07-06 |
| NO20013369L NO20013369L (no) | 2001-09-03 |
Family
ID=22849500
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20013369A NO20013369L (no) | 1999-01-07 | 2001-07-06 | Arylpiperazinyl-cykloheksyl-indol-derivater for behandling av depresjon |
Country Status (19)
| Country | Link |
|---|---|
| EP (1) | EP1147083B1 (no) |
| JP (1) | JP2002534411A (no) |
| KR (1) | KR20010086163A (no) |
| CN (1) | CN1166636C (no) |
| AR (1) | AR028810A1 (no) |
| AT (1) | ATE269303T1 (no) |
| AU (1) | AU2490900A (no) |
| BR (1) | BR0007424A (no) |
| CA (1) | CA2355342A1 (no) |
| CZ (1) | CZ20012444A3 (no) |
| DE (1) | DE60011570T2 (no) |
| DK (1) | DK1147083T3 (no) |
| ES (1) | ES2219302T3 (no) |
| HU (1) | HUP0200309A3 (no) |
| IL (1) | IL143979A0 (no) |
| NO (1) | NO20013369L (no) |
| PT (1) | PT1147083E (no) |
| WO (1) | WO2000040554A1 (no) |
| ZA (1) | ZA200105190B (no) |
Families Citing this family (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6337326B1 (en) * | 1999-11-08 | 2002-01-08 | American Home Products Corporation | N-aryl-(homopiperazinyl)-cyclohexyl amines |
| WO2001034598A1 (en) * | 1999-11-08 | 2001-05-17 | Wyeth | [(indol-3-yl)-cycloalkyl]-3-substituted azetidines for the treatment of central nervous system disorders |
| IL156595A0 (en) * | 2001-01-16 | 2004-01-04 | Astrazeneca Ab | Therapeutic heterocyclic compounds |
| CN1821236B (zh) * | 2001-01-16 | 2010-06-23 | 阿斯特拉曾尼卡有限公司 | 治疗性杂环化合物 |
| EP1373203A1 (en) | 2001-03-29 | 2004-01-02 | Bristol-Myers Squibb Company | Cyclopropylindole derivatives as selective serotonin reuptake inhibitors |
| WO2003007956A1 (en) | 2001-07-20 | 2003-01-30 | Psychogenics, Inc. | Treatment for attention-deficit hyperactivity disorder |
| SE0103649D0 (sv) * | 2001-11-01 | 2001-11-01 | Astrazeneca Ab | Therapeutic quinoline compounds |
| SE0103648D0 (sv) * | 2001-11-01 | 2001-11-01 | Astrazeneca Ab | Therapeutic quinolone compounds |
| GB0227240D0 (en) * | 2002-11-21 | 2002-12-31 | Glaxo Group Ltd | Compounds |
| US7276603B2 (en) | 2003-05-02 | 2007-10-02 | Wyeth | Benzofuranyl-and benzothienyl-piperazinyl quinolines and methods of their use |
| JP2008503469A (ja) | 2004-06-17 | 2008-02-07 | ワイス | ゴナドトロピン放出ホルモン受容体アンタゴニスト |
| NZ552093A (en) | 2004-06-17 | 2009-06-26 | Wyeth Corp | Processes for preparing gonadotropin releasing hormone receptor antagonists |
| JP5186219B2 (ja) | 2005-01-25 | 2013-04-17 | エピックス デラウェア， インコーポレイテッド | 置換アリールアミン化合物および５−ｈｔ６調節因子としてのその使用 |
| US7538113B2 (en) | 2005-02-18 | 2009-05-26 | Wyeth | 4-substituted imidazo[4,5-c]pyridine antagonists of gonadotropin releasing hormone receptor |
| US7582634B2 (en) | 2005-02-18 | 2009-09-01 | Wyeth | 7-substituted imidazo[4,5-c]pyridine antagonists of gonadotropin releasing hormone receptor |
| US7534796B2 (en) | 2005-02-18 | 2009-05-19 | Wyeth | Imidazo[4,5-b]pyridine antagonists of gonadotropin releasing hormone receptor |
| US7531542B2 (en) | 2005-05-18 | 2009-05-12 | Wyeth | Benzooxazole and benzothiazole antagonists of gonadotropin releasing hormone receptor |
| US7582636B2 (en) | 2005-05-26 | 2009-09-01 | Wyeth | Piperazinylimidazopyridine and piperazinyltriazolopyridine antagonists of Gonadotropin Releasing Hormone receptor |
| TW200800959A (en) | 2005-06-10 | 2008-01-01 | Wyeth Corp | Piperazine-piperidine antagonists and agonists of the 5-HT1a receptor |
| TW200808730A (en) * | 2006-06-09 | 2008-02-16 | Wyeth Corp | Process for synthesizing piperazine-piperidine compounds |
| TW200819457A (en) | 2006-08-30 | 2008-05-01 | Actelion Pharmaceuticals Ltd | Spiro antibiotic derivatives |
| AR063984A1 (es) * | 2006-11-28 | 2009-03-04 | Wyeth Corp | Metabolitos de 5-fluoro-8-{4-[4-(6-metoxiquinolin-8-il)piperazin-1-il]piperidin-1-il}quinolina, metodos de preparacion, su uso en la fabricacion de medicamentos para el tratamiento de trastornos relacionados con 5-ht1a, composicion farmaceutica que los comprende, compuestos radioetiquetados derivado |
| CL2008001003A1 (es) | 2007-04-11 | 2008-10-17 | Actelion Pharmaceuticals Ltd | Compuestos derivados de oxazolidinona; composicion farmaceutica que comprende a dichos compuestos; y su uso para preparar un medicamento para tratar una infeccion bacteriana. |
| CL2008001002A1 (es) | 2007-04-11 | 2008-10-17 | Actelion Pharmaceuticals Ltd | Compuestos derivados de oxazolidinona; composicion farmaceutica que comprende a dichos compuestos; y su uso para preparar un medicamento para tratar una infeccion bacteriana. |
| DE102007028925A1 (de) * | 2007-06-22 | 2008-12-24 | Saltigo Gmbh | Verfahren zur Herstellung von 2-Phenoxyacetalen und den daraus korrespondierenden 2-Phenoxycarbaldehyden |
| BRPI0820985A2 (pt) | 2007-12-18 | 2015-06-16 | Actelion Pharmaceuticals Ltd | Composto derivado de 5-aminociclometil-oxazondin-2-ona, medicamento e composição farmacêutica que os contém e uso dos mesmos |
| KR100970606B1 (ko) * | 2008-10-08 | 2010-07-20 | 장경분 | 향초 및 이를 위한 제조방법 |
| SG10201405826RA (en) | 2009-06-17 | 2014-12-30 | Vertex Pharma | Inhibitors of influenza viruses replication |
| RU2013132681A (ru) | 2010-12-16 | 2015-01-27 | Вертекс Фармасьютикалз Инкорпорейтед | Ингибиторы репликации вирусов гриппа |
| UA118010C2 (uk) | 2011-08-01 | 2018-11-12 | Вертекс Фармасьютікалз Інкорпорейтед | Інгібітори реплікації вірусів грипу |
| PT3068776T (pt) | 2013-11-13 | 2019-08-26 | Vertex Pharma | Inibidores da replicação de vírus da gripe |
| WO2015073481A1 (en) | 2013-11-13 | 2015-05-21 | Vertex Pharmaceuticals Incorporated | Methods of preparing inhibitors of influenza viruses replication |
| CN103724276A (zh) * | 2013-12-13 | 2014-04-16 | 成都丽璟科技有限公司 | 一种由硝基苯胺制备苯并咪唑类化合物的新方法 |
| EP3083589B1 (en) * | 2013-12-20 | 2019-12-18 | Sunshine Lake Pharma Co., Ltd. | Substituted piperazine compounds and methods of use thereof |
| CN104725363B (zh) * | 2013-12-20 | 2019-03-01 | 广东东阳光药业有限公司 | 取代的哌嗪化合物及其使用方法和用途 |
| JP6704416B2 (ja) | 2015-05-13 | 2020-06-03 | バーテックス ファーマシューティカルズ インコーポレイテッドＶｅｒｔｅｘ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｃｏｒｐｏｒａｔｅｄ | インフルエンザウイルスの複製の阻害剤を調製する方法 |
| EP3294735B8 (en) | 2015-05-13 | 2022-01-05 | Vertex Pharmaceuticals Incorporated | Inhibitors of influenza viruses replication |
| US10316025B2 (en) * | 2015-06-03 | 2019-06-11 | Sunshine Lake Pharma Co., Ltd. | Substituted piperazine compounds and methods of use and use thereof |
| CN109467554B (zh) * | 2017-09-07 | 2022-05-10 | 上海医药工业研究院 | 吲哚-芳杂环哌嗪(啶)类衍生物及其在抗抑郁症中的应用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4954502A (en) * | 1988-06-10 | 1990-09-04 | Bristol-Myers Squibb Company | 1-indolyalkyl-4-(substituted-pyridinyl)piperazines |
| US5468767A (en) * | 1994-01-06 | 1995-11-21 | Bristol-Myers Squibb Company | Antidepressant 3-(aminocycloalkenyl)-indole-5-nitrile derivatives |
| DE19512639A1 (de) * | 1995-04-05 | 1996-10-10 | Merck Patent Gmbh | Benzonitrile und -fluoride |
-
2000
- 2000-01-06 EP EP00903114A patent/EP1147083B1/en not_active Expired - Lifetime
- 2000-01-06 KR KR1020017008567A patent/KR20010086163A/ko not_active Withdrawn
- 2000-01-06 ES ES00903114T patent/ES2219302T3/es not_active Expired - Lifetime
- 2000-01-06 DK DK00903114T patent/DK1147083T3/da active
- 2000-01-06 AU AU24909/00A patent/AU2490900A/en not_active Abandoned
- 2000-01-06 PT PT00903114T patent/PT1147083E/pt unknown
- 2000-01-06 AT AT00903114T patent/ATE269303T1/de not_active IP Right Cessation
- 2000-01-06 CZ CZ20012444A patent/CZ20012444A3/cs unknown
- 2000-01-06 JP JP2000592263A patent/JP2002534411A/ja not_active Withdrawn
- 2000-01-06 BR BR0007424-1A patent/BR0007424A/pt not_active Application Discontinuation
- 2000-01-06 DE DE60011570T patent/DE60011570T2/de not_active Expired - Fee Related
- 2000-01-06 HU HU0200309A patent/HUP0200309A3/hu unknown
- 2000-01-06 IL IL14397900A patent/IL143979A0/xx unknown
- 2000-01-06 WO PCT/US2000/000223 patent/WO2000040554A1/en not_active Ceased
- 2000-01-06 CN CNB008026084A patent/CN1166636C/zh not_active Expired - Fee Related
- 2000-01-06 CA CA002355342A patent/CA2355342A1/en not_active Abandoned
- 2000-01-06 AR ARP000100049A patent/AR028810A1/es not_active Application Discontinuation
-
2001
- 2001-06-22 ZA ZA200105190A patent/ZA200105190B/en unknown
- 2001-07-06 NO NO20013369A patent/NO20013369L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| AR028810A1 (es) | 2003-05-28 |
| AU2490900A (en) | 2000-07-24 |
| EP1147083A1 (en) | 2001-10-24 |
| DE60011570D1 (de) | 2004-07-22 |
| ES2219302T3 (es) | 2004-12-01 |
| KR20010086163A (ko) | 2001-09-08 |
| ATE269303T1 (de) | 2004-07-15 |
| WO2000040554A1 (en) | 2000-07-13 |
| ZA200105190B (en) | 2002-09-23 |
| HUP0200309A2 (en) | 2002-06-29 |
| PT1147083E (pt) | 2004-09-30 |
| CN1336916A (zh) | 2002-02-20 |
| CA2355342A1 (en) | 2000-07-13 |
| JP2002534411A (ja) | 2002-10-15 |
| NO20013369L (no) | 2001-09-03 |
| BR0007424A (pt) | 2001-10-09 |
| IL143979A0 (en) | 2002-04-21 |
| DK1147083T3 (da) | 2004-08-16 |
| EP1147083B1 (en) | 2004-06-16 |
| CN1166636C (zh) | 2004-09-15 |
| HUP0200309A3 (en) | 2003-05-28 |
| DE60011570T2 (de) | 2004-11-25 |
| CZ20012444A3 (cs) | 2002-02-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20013369D0 (no) | Arylpiperazinyl-cykloheksyl-indol-derivater for behandling av depresjon | |
| NO20013380D0 (no) | 2-aminobenzoksazinonderivater for behandling av fedme | |
| NO20013381D0 (no) | 2-oksybenzoksazinonderivater for behandling av fedme | |
| NO20014379D0 (no) | Anvendelse av Xenon for behandling av Neurointoksikasjoner | |
| NO20021400D0 (no) | Terapeutiske konazolinderivater | |
| NO20021474L (no) | Forbindelser for behandling av ischemi | |
| NO20022087D0 (no) | Fremgangsmåte for behandling av diabetes | |
| NO20024775D0 (no) | Hydroksyfenyl-piperidin-4-yliden-metyl-benzamidderivater til behandling av smerte | |
| NO20013507L (no) | Blandinger for behandling av inflammatoriske reaksjoner | |
| NO20022245L (no) | Onkolyttiske kombinasjoner for behandling av cancer | |
| NO20024776D0 (no) | Hydroksyfenyl-piperazinyl-metyl-benzamidderivater til behandling av smerte | |
| NO20024777L (no) | Kinolinyl-piperidin-4-yliden-metyl-benzamid derivater til behandling av smerte | |
| NO20020784L (no) | Medikament for behandling av brudd | |
| NO20012541D0 (no) | Anvendelse av fosfonomaursyrederivater for behandling av infeksjoner | |
| PT1178984E (pt) | Derivados de 1-trifluorometil-4-hidroxi-7-piperidinilamimometilcromano | |
| NO20012612L (no) | Isonipecotamider for behandlingen av integrin-formidlede sykdommer | |
| NO20014845D0 (no) | Anvendelse av arylalkanoylpyridaziner | |
| NO20014026L (no) | Krampestillende derivater til behandling av betydelig skjelving | |
| NO20012540D0 (no) | Anvendelse av fosfonomaursyrederivater for behandling av infeksjoner | |
| NO20016030L (no) | Derivater av 4'-demykarosyl-8a-aza-8a-homotylosin | |
| NO20020328D0 (no) | Fremgangsmåte for fremstilling av 4-cyano-2-aminometyltiazol | |
| NO20020327D0 (no) | Fremgangsmåte for fremstilling av 2-aminometyl-4-cyano-tiazol | |
| PT1232141E (pt) | Eteres de o-desmetil-venlafaxina | |
| NO20005856L (no) | Anvendelse av 1,1-diokso-perhydro-1,2,4-tiadiaziner | |
| AU4475300A (en) | Tetrahydroisoquinolinyl-indole derivatives for the treatment of depression |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |